FAQs
What are ROVI's activities in the pharmaceutical market at present?
In which pharmaceutical areas is ROVI present?
What are the main factors in ROVI’s strategy?
News
6/05/2026
First three months of 2026 results press release
- Total revenue in the first quarter of 2026 amounted to 154.7 million euros, in line with the same period of the previous year.
1/04/2026
ROVI announces the closing of the Asset Purchase Agreement entered into in September 2025 for the acquisition of a pharmaceutical manufacturing facility in Phoenix, Arizona (USA)
In compliance with the disclosure obligations set forth in Article 227 of Law 6/2023, of 17 March, on Securities Markets and Investment Services, and as a follow-up to the disclosure of inside info
25/02/2026
2025 results press release
- Total revenue in 2025 was 756.1 million euros, a 1% decrease on 2024.
Contact
At ROVI, we have a policy of transparency and direct communication. Therefore, you may contact us directly whenever you need to do so.
ROVI
Head Offices
Julián Camarillo 35
28037 Madrid - Spain
28037 Madrid - Spain
Tel +(34) 91 375 62 30
Fax +(34) 91 375 62 30
Email: rovi@rovi.es